|
1
|
Shaheen Z, BenHamed NA and Elhamdani RM:
MON-436 cribriform-morular variant of papillary thyroid carcinoma:
A case report. J Endocr Soc. 4(Suppl 1): MON-4362020. View Article : Google Scholar :
|
|
2
|
Frates MC, Benson CB, Charboneau JW, Cibas
ES, Clark OH, Coleman BG, Cronan JJ, Doubilet PM, Evans DB,
Goellner JR, et al: Management of thyroid nodules detected at US:
Society of radiologists in ultrasound consensus conference
statement. Ultrasound Q. 22:231–240. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Papini E, Guglielmi R, Bianchini A,
Crescenzi A, Taccogna S, Nardi F, Panunzi C, Rinaldi R, Toscano V
and Pacella CM: Risk of malignancy in nonpalpable thyroid nodules:
Predictive value of ultrasound and color-Doppler features. J Clin
Endocrinol Metab. 87:1941–1946. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Frates MC, Benson CB, Doubilet PM,
Kunreuther E, Contreras M, Cibas ES, Orcutt J, Moore FD Jr, Larsen
PR, Marqusee E and Alexander EK: Prevalence and distribution of
carcinoma in patients with solitary and multiple thyroid nodules on
sonography. J Clin Endocrinol Metab. 91:3411–3417. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yassa L, Cibas ES, Benson CB, Frates MC,
Doubilet PM, Gawande AA, Moore FD Jr, Kim BW, Nosé V, Marqusee E,
et al: Long-term assessment of a multidisciplinary approach to
thyroid nodule diagnostic evaluation. Cancer. 111:508–516. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Haugen BR: 2015 American thyroid
association management guidelines for adult patients with thyroid
nodules and differentiated thyroid cancer: What is new and what has
changed? Cancer. 123:372–381. 2017. View Article : Google Scholar
|
|
7
|
Wang CC, Friedman L, Kennedy GC, Wang H,
Kebebew E, Steward DL, Zeiger MA, Westra WH, Wang Y, Khanafshar E,
et al: A large multicenter correlation study of thyroid nodule
cytopathology and histopathology. Thyroid. 21:243–251. 2011.
View Article : Google Scholar
|
|
8
|
Maher B: ENCODE: The human encyclopedia.
Nature. 489:46–48. 2012. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dianatpour A and Ghafouri-Fard S: Long
non-coding RNA expression intersecting cancer and spermatogenesis:
A systematic review. Asian Pac J Cancer Prev. 18:2601–2610.
2017.PubMed/NCBI
|
|
10
|
He JH, Han ZP and Li YG: Association
between long non-coding RNA and human rare diseases (Review).
Biomed Rep. 2:19–23. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Maruyama R, Suzuki H, Yamamoto E, Imai K
and Shinomura Y: Emerging links between epigenetic alterations and
dysregulation of noncoding RNAs in cancer. Tumour Biol. 33:277–285.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Mercer TR, Dinger ME and Mattick JS: Long
non-coding RNAs: Insights into functions. Nat Rev Genet.
10:155–159. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu YC, Wang AM, Lu JK, Cen R and Liu LL:
Long noncoding RNA HOXD-AS1 regulates proliferation of cervical
cancer cells by activating Ras/ERK signaling pathway. Eur Rev Med
Pharmacol Sci. 21:5049–5055. 2017.PubMed/NCBI
|
|
14
|
Adriaens C and Marine JC: NEAT1-containing
paraspeckles: Central hubs in stress response and tumor formation.
Cell Cycle. 16:137–138. 2017. View Article : Google Scholar :
|
|
15
|
Choudhry H and Mole DR: Hypoxic regulation
of the noncoding genome and NEAT1. Brief Funct Genomics.
15:174–185. 2016. View Article : Google Scholar :
|
|
16
|
Xie Q, Lin S, Zheng M, Cai Q and Tu Y:
Long noncoding RNA NEAT1 promotes the growth of cervical cancer
cells via sponging miR-9-5p. Biochem Cell Biol. 97:100–108. 2019.
View Article : Google Scholar
|
|
17
|
Ma Y, Liu L, Yan F, Wei W, Deng J and Sun
J: Enhanced expression of long non-coding RNA NEAT1 is associated
with the progression of gastric adenocarcinomas. World J Surg
Oncol. 14:412016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gao C, Zhang J, Wang Q and Ren C:
Overexpression of lncRNA NEAT1 mitigates multidrug resistance by
inhibiting ABCG2 in leukemia. Oncol Lett. 12:1051–1057. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu E, Su J, Zeng W and Zhang C: Enhanced
miR-9 promotes laryngocarcinoma cell survival via down-regulating
PTEN. Biomed Pharmacother. 84:608–613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng N and Guo Y: Long noncoding RNA
NEAT1 promotes nasopharyngeal carcinoma progression through
regulation of miR-124/NF-κB pathway. Onco Targets Ther.
10:5843–5853. 2017. View Article : Google Scholar :
|
|
21
|
Zhang L, Chen X, Liu B and Han J:
MicroRNA-124-3p directly targets PDCD6 to inhibit metastasis in
breast cancer. Oncol Lett. 15:984–990. 2018.PubMed/NCBI
|
|
22
|
Yu S, Liu X, Zhang Y, Li J, Chen S, Zheng
H, Reng R, Zhang C, Chen J and Chen L: Circulating microRNA124-3p,
microRNA9-3p and microRNA196b-5p may be potential signatures for
differential diagnosis of thyroid nodules. Oncotarget.
7:84165–84177. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lei H, Gao Y and Xu X: LncRNA TUG1
influences papillary thyroid cancer cell proliferation, migration
and EMT formation through targeting miR-145. Acta Biochim Biophys
Sin (Shanghai). 49:588–597. 2017. View Article : Google Scholar
|
|
24
|
Bartolazzi A, Sciacchitano S and
D'Alessandria C: Galectin-3: The impact on the clinical management
of patients with thyroid nodules and future perspectives. Int J Mol
Sci. 19:4452018. View Article : Google Scholar :
|
|
25
|
Zhang YZ, Xu T, Gong HY, Li CY, Ye XH, Lin
HJ, Shen MP, Duan Y, Yang T and Wu XH: Application of
high-resolution ultrasound, real-time elastography, and
contrast-enhanced ultrasound in differentiating solid thyroid
nodules. Medicine (Baltimore). 95:e53292016. View Article : Google Scholar
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
27
|
Morselli E, Galluzzi L, Kepp O, Vicencio
JM, Criollo A, Maiuri MC and Kroemer G: Anti- and pro-tumor
functions of autophagy. Biochim Biophys Acta. 1793:1524–1532. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Su CH, Chen LJ, Liao JF and Cheng JT:
Increase of phosphatase and tensin homolog by silymarin to inhibit
human pharynx squamous cancer. J Med Food. 16:778–784. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Eng C: PTEN: One gene, many syndromes. Hum
Mutat. 22:183–198. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hobert JA, Embacher R, Mester JL, Frazier
TW II and Eng C: Biochemical screening and PTEN mutation analysis
in individuals with autism spectrum disorders and macrocephaly. Eur
J Hum Genet. 22:273–276. 2014. View Article : Google Scholar :
|
|
31
|
Vito P, Lacanà E and D'Adamio L:
Interfering with apoptosis: Ca(2+)-binding protein ALG-2 and
Alzheimer's disease gene ALG-3. Science. 271:521–525. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maki M, Narayana SV and Hitomi K: A
growing family of the Ca2+-binding proteins with five
EF-hand motifs. Biochem J. 328:718–720. 1997.
|
|
33
|
Ohkouchi S, Nishio K, Maeda M, Hitomi K,
Adachi H and Maki M: Identification and characterization of two
penta-EF-hand Ca(2+)-binding proteins in Dictyostelium discoideum.
J Biochem. 130:207–215. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Su D, Xu H, Feng J, Gao Y, Gu L, Ying L,
Katsaros D, Yu H, Xu S and Qi M: PDCD6 is an independent predictor
of progression free survival in epithelial ovarian cancer. J Transl
Med. 10:312012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
la Cour JM, Høj BR, Mollerup J, Simon R,
Sauter G and Berchtold MW: The apoptosis linked gene ALG-2 is
dysregu-lated in tumors of various origin and contributes to cancer
cell viability. Mol Oncol. 1:431–439. 2008. View Article : Google Scholar
|
|
36
|
Jiang X, Zhou Y, Sun AJ and Xue JL: NEAT1
contributes to breast cancer progression through modulating miR-448
and ZEB1. J Cell Physiol. 233:8558–8566. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao D, Zhang Y, Wang N and Yu N: NEAT1
negatively regulates miR-218 expression and promotes breast cancer
progression. Cancer Biomark. 20:247–254. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Han D, Wang J and Cheng G: LncRNA NEAT1
enhances the radio-resistance of cervical cancer via
miR-193b-3p/CCND1 axis. Oncotarget. 9:2395–2409. 2017. View Article : Google Scholar
|
|
39
|
Souquere S, Beauclair G, Harper F, Fox A
and Pierron G: Highly ordered spatial organization of the
structural long noncoding NEAT1 RNAs within paraspeckle nuclear
bodies. Mol Biol Cell. 21:4020–4027. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Yu X, Li Z, Zheng H, Chan MT and Wu WK:
NEAT1: A novel cancer-related long non-coding RNA. Cell Prolif.
50:e123292017. View Article : Google Scholar
|
|
41
|
Chai Y, Liu J, Zhang Z and Liu L:
HuR-regulated lncRNA NEAT1 stability in tumorigenesis and
progression of ovarian cancer. Cancer Med. 5:1588–1598. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Idogawa M, Ohashi T, Sasaki Y, Nakase H
and Tokino T: Long non-coding RNA NEAT1 is a transcriptional target
of p53 and modulates p53-induced transactivation and
tumor-suppressor function. Int J Cancer. 140:2785–2791. 2017.
View Article : Google Scholar : PubMed/NCBI
|
